Defining the prognostic value for Galectin-3 in cutaneous melanoma

Journal of International Medical Research

Volumn 35, Issue 5, 2007, Pages 731-732

  Vereecken, P ^a,b,e   Ghanem, G ^b   Morandini, R ^b   Suciu, S ^c   Van Baren, N ^d   Heenen, M ^a  

^a ERASME HOSPITAL   (Belgium)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c EORTC DATA CENTER   (Belgium)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^e NONE   (Belgium)

Author keywords

Biomarker; Galectin 3; Melanoma

Indexed keywords

GALECTIN 3;

CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL MOTILITY; CELL NUCLEUS; CELLULAR DISTRIBUTION; CORRELATION FUNCTION; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MELANOMA; METASTASIS; NEVUS; PHENOTYPE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN CARCINOGENESIS;

EID: 35348877907     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000703500520     Document Type: Letter

References (6)

1. Liu FT, Rabinovich GA: Galectins as modulators of turnout progression. Nat Rev Cancer 2005; 5: 29-41.
2. Califice S, Castronovo V, Van Den Brule F: Galectin-3 and cancer. Int J Oncol 2004; 25: 983-992.
3. Prieto VG, Mourad-Zeidan AA, Melnikova V, et al: Galectin-3 expression is associated with tumor progression and pattern of san exposure in melanoma. Clin Cancer Res 2006; 12: 6709-6715.
4. Vereecken P, Heenen M: Serum galectin-3 in advanced melanoma patients: a hypothesis on a possible role in melanoma progression and inflammation. J Int Med Res 2006; 34: 119-120.
5. Vereecken P, Debray C, Petein M, et al: Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors. Arch Dermatol Res 2005; 296: 353-358.
6. Vereecken P, Zouaoui Boudjeltia K, Debray C, et al: High serum galectin-3 in advanced melanoma: preliminary results. Clin Exp Dermatol 2006; 31: 105-109.